OpenAI's IPO delay turns SoftBank into the proxy bet on whether generative AI is investable

SoftBank Group shares fell more than 12% on the Tokyo session of Friday 26 June 2026, after a report that OpenAI is weighing a 2027 listing rather than moving sooner. Nikkei Asia reported the move in early Asian trade, attributing the slide to disappointed investors engaging in profit-taking; CryptoBriefing flagged the same session through its Telegram wire. The trigger was a single sentence inside a broader funding story: OpenAI, the report suggested, is now looking at 2027 for an IPO, sequenced behind Anthropic's expected debut.

By Friday afternoon UTC the picture had hardened in two places at once. SoftBank — OpenAI's largest single external backer and the listed vehicle through which Masayoshi Son's AI thesis sits in public-equity portfolios — had lost more than a tenth of its value on a single day. And on the prediction market Polymarket, traders were pricing Anthropic as a 77% favourite to go public before OpenAI, a level that turned the original hierarchy on its head. The two data points together describe a market that has effectively rerated SoftBank not as a diversified technology investor but as a leveraged call option on a single private company's exit calendar.

What changed on Friday

The session opened in Asia. Nikkei's Friday-morning dispatch framed the move as a profit-taking event tied to a specific catalyst: the prospect that OpenAI's public-market debut, long treated by SoftBank's investor base as the validation moment for Son's AI build-out, was sliding right. CryptoBriefing carried the same report into a global crypto-and-markets audience, citing the possibility that OpenAI's IPO could land in 2027 rather than 2026, and noting that Anthropic's own listing was expected to come first. SoftBank's 12% slide in Tokyo is, in that framing, the cleanest possible read on how dependent the listed equity has become on a single unverified event at an unlisted firm in San Francisco.

A second-order print sat underneath the price action. Polymarket's market on which frontier-lab would list first — Anthropic or OpenAI — moved to a 77% implied probability of Anthropic going first, per the snapshot posted to X on Friday. That is not, on its own, a forecast of either company's eventual valuation; it is a calendar trade. But it is the calendar that SoftBank's own narrative requires to land at a particular multiple.

The structural frame, in plain terms

What the session illustrated is the conversion of a venture-style bet into a public-equity liability. SoftBank's Vision Fund era was premised on the argument that late-stage private technology, held inside a listed holding company, would compound for shareholders as a private-asset substitute. The model works when two things are true: the underlying assets keep marking up, and the listed vehicle trades at a discount that periodically closes. On Friday, the second leg of that trade was tested. The first leg — the marks — is harder to read, because there is no public tape for OpenAI.

Into that vacuum stepped the Polymarket print, which functions as a thin but real price on the relative timing of two private exits. In effect, retail and professional traders who cannot buy OpenAI shares are now trading the sequence of OpenAI and Anthropic listings as the cleanest available proxy for what Son is being told inside the data room. A 77% probability that Anthropic goes first is, translated, a market saying it expects the AI-lab IPO calendar to validate Anthropic's governance and compute economics ahead of OpenAI's. SoftBank is short that sequence. That is what 12% on a Friday morning means.

Who wins and who loses if 2027 holds

The obvious loser on the news is SoftBank itself, and by extension the long-only investors and pension allocators who own the stock as a quasi-passive AI index. The shorter the gap between now and an OpenAI print, the more the holding-company discount compresses; the longer the gap, the more that discount reasserts.

A second set of losers sits in the AI-lab founder economy. If the calendar slides, the entire 2024–2025 cohort of generative-AI staff whose compensation is denominated in restricted stock at strike prices that assume a 2026 listing now faces a longer vesting horizon and a more uncertain mark. That has knock-on effects on retention, on secondaries markets that have already begun to clear at modest discounts, and on the talent flows between OpenAI and Anthropic themselves.

The relative winner, on the framing the market is currently endorsing, is Anthropic. A listing first gives Anthropic the floor to set the public-market valuation reference for frontier-model companies, the float to recruit engineers off post-vesting cliffs, and the regulatory engagement that comes from being a registered US issuer. From Beijing to Brussels, the first frontier lab to file an S-1 also sets the disclosure template the second lab must either match or diverge from. SoftBank's Friday slide is, in that reading, the market pricing Anthropic as the agenda-setter.

What the sources do not yet tell us

The Friday prints are precise on two things: SoftBank's price move and Polymarket's implied probability. They are imprecise on three others. The reports characterise the OpenAI delay as a consideration — OpenAI "considers" 2027, the IPO "could" come then — rather than a stated policy. The underlying OpenAI rationale for any delay is not in the source material: it may be capital structure, it may be governance, it may be waiting for a cleaner macro window, and the sources do not distinguish. And the relationship between Anthropic's "expected" debut and any actual filing date is asserted rather than documented; the Polymarket price is the cleanest available read on expectation, not on filings.

Monexus also flags one reading the wires are not yet steelmanning. A 2027 OpenAI listing is not, on its own, a negative signal for the AI thesis. It can equally be read as a rational response to a higher long-run valuation if private capital remains available, or as a posture that lets the company avoid a 2026 tape that has compressed multiples for software listings broadly. The market on Friday read the headline as a SoftBank-specific negative; the structural read is more ambiguous.

Desk note

*The wire coverage treated Friday's slide as a SoftBank story and a SoftBank story alone. Monexus frames it as a wider test of whether listed vehicles can credibly warehouse private AI exposure at scale — a question on which SoftBank is currently the only public data point that moves on the calendar of a single San Francisco lab.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://t.me/CryptoBriefing
• https://t.me/CryptoBriefing
• https://t.me/CryptoBriefing
• https://t.me/NikkeiAsia
• https://t.me/nikkeiasia